Global healthcare is being led by the US with China following close behind. Europe is simply being a spectator to the developments that are unfolding on a global level.
A startup company called Nanochon secure 1st place at the 3DHEALS conference this year after delivering its pitch to a group of investors including Asimov Ventures, GE Ventures, Digital Industrialist.
A new form of the deadly disease named pneumoconiosis or black lung disease has become more prevalent especially among coal miners in the US, with mining experience of more than ten years.
The research study revealed that tumor growth could be reduced by targeting the expression of Beta3-integrin along with microtubule-targeting agents (MTAs) chemotherapy. Beta3-integrin was the better anti-angiogenic target since it was expressed in tumor blood vessels, unlike normal cells.
To diagnose any kind of gastrointestinal problems, an ingestible sensor equipped with a genetically engineered bacteria was developed by an MIT research team. This ‘bacteria-on-a-chip’ combined sensors with ultra-low-power electronics, which could convert the bacterial response into a wireless signal that can be read by a smartphone.
It is always advised to drink water. But recent studies have shown that there may be a limit as to how much. Overconsumption of water causes a decrease in sodium levels and fluid accumulates excessively in the brain, which leads to its swelling. This life-threatening condition, termed as Hyponatremia, is more commonly prevalent among the elderly.
Lou Gehrig disease which has no cure is finally seeing a ray of hope by Tel Aviv University researchers. The disease also called Amyotrophic lateral sclerosis (ALS) a neurodegenerative issue which causes muscles to atrophy and produces permanent disability in patients. The investigators say they may have found the basis of what could become a treatment for the devastating disease.
In a major setback for Eisai and Merck & Co, the FDA has stalled the roll-out of Lenvima as a treatment for earlier untreated liver cancer patients. Big things were expected by Merck & Co when Eisai’s Lenvima was scheduled to be launched in March. Merck has agreed to shell out USD 5.8 billion on half of the liver cancer’s drug sales.
The IVD sector in the country is chiefly characterized by 70 percent laboratories offering pathology services and 30 percent entities doling out radiology and imaging services. Though domestic players are flexing their muscles and are gearing to provide new-age diagnostic services with path-breaking innovations and strategic investments, multinational companies continue to hold sway over 60% of the domestic IVD market which is expected to grow by leaps and bounds in coming times.
The appearance and smell of urine could intimate a lot about the person’s health. Due to the presence of waste contents in urine, it might look or smell unusual.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.